Loading...

Investors

NEUTRISCI ANNOUNCES LAUNCH OF NEW AMBASSADOR DIRECT SALES CHANNEL

VANCOUVER, BC – March 21, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the launch of its ambassador marketing program for neuenergy®.

The Company has been beta testing the program for several months, and it is now being opened to ambassadors around the world, with an initial focus on North America, Europe and Southeast Asia.

The neuenergy® Ambassador Marketing Program (NAMP), allows the Company to build out a network of influencers, public figures, celebrities and entrepreneurs to help expand the neuenergy® brand. Commissions are earned from online sales that are generated from the direct referral of the Ambassador. This program is ideal for influencers, public figures, celebrities and entrepreneurs that the Company identifies as a good fit for the brand and product. It will give them the opportunity to monetize their social networks by generating sales of neuenergy® through their own referral network.

NeutriSci President Mr. Glen Rehman stated, “A solid brand ambassador program creates mutual benefits with cost-effective promotion for both parties. Ambassadors boost brand awareness in the target market and drive sales in a less expensive way than traditional channels. Our Ambassador program will promote trusted faces thus positively reinforcing neuenergy to their readers and followers. Ambassadors benefit because they receive commission on every sale they refer however these commissions only come from customers who convert, so both businesses and ambassadors benefit from a transparent and efficient working arrangement. We are very excited about the level of interest this program has already achieved, and look forward to announcing industry leading Ambassadors over the next few weeks.”

Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about neuenergy®, please visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ANNOUNCES DISTRIBUTION AGREEMENT & INITIAL ORDER OF NEUENERGY FROM GATEWAY NEWSTANDS

Vancouver, British Columbia – March 16, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce that neuenergy® is now available at Gateway Newstands across Canada and the United States.

Gateway Newstands is a chain of convenience stores and kiosks located in large office buildings, shopping centres, public places, and transit stations in the United States and Canada.

There are currently over 500 Gateway Newstand franchises in the network, of which 65 locations have been operated in the Toronto subway system since the mid-1990s. The stores sell a wide variety of convenience items from tobacco and lottery tickets; to candy, chewing gum, and non-alcoholic beverages; and newspapers and magazines.

NeutriSci President Mr. Glen Rehman stated, “We are very pleased to continue the expansion of our North American distribution network with such a strong company as Gateway Newstands. Gateway Newstands has a very captive audience as a result of the strategic placing of their stores in high traffic locations. In addition to Gateway Newstands, neuenergy is also available in a growing network of retailers that includes 7-Eleven, Save-on-Foods, Buy-Low, Sobey’s/Safeway, Mac’s, Overwaitea, Amazon and Meijer.”

Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about neuenergy®, please visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI LAUNCHES NATIONAL TELEVISION AD CAMPAIGN

Vancouver, British Columbia – March 09, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, is pleased to announce the launch of its national television campaign for neuenergy®.

The campaign consists of more than 1,400 thirty second spots over a 4-week period. The spots are airing now on major cable networks including, TSN, TSN2, Discovery, Discovery Velocity, National Geographic, Action, Game Show and BNN.

This is the first major ad campaign for neuenergy® in Canada, and coincides with the increasing demand for neuenergy® in the more “grown-up” segment of the Canadian energy drink and supplement market, which recorded sales in excess to $475 million in 2015.

To view commercial click on the link:

Neuenergy Commercial

NeutriSci President Mr. Glen Rehman stated, “This latest news helps solidify neuenergy as a competitive player in the Canadian market place. Neuenergy is now available across Canada with added distribution to be announced in the coming weeks. Our expanded national distribution provided us the ability to proceed with this major ad campaign as it allowed us to reach economies of scale. This television commercial represents the first of many national media campaigns planned for 2017.”

Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about neuenergy®, and to view this new television commercial, visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ANNOUNCES OTCQB LISTING

Vancouver, British Columbia – March 06, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9) is pleased to announce that it has commenced trading on the OTCQB Marketplace under the symbol NRXCF.

NeutriSci President, Glen Rehman commented, “We are pleased to have been added to the OTCQB Marketplace. The Company’s common shares are now trading on three international platforms: TSX Venture (Canada), OTCQB (USA) and Frankfurt (Germany). Given the progress that the Company is making with the retail distribution of its energy supplement, neuenergy, and with its work on the neuenergy-CBD product that is being developed in partnership with Lexaria Bioscience, we believe that this most recent US listing will create greater visibility with US investors, allowing a much larger potential shareholder base and enhanced liquidity.”

The Company also announces that Arlene Dickinson has resigned as a director of the Company to focus on other endeavours. The Company thanks Arlene for her valuable marketing contributions to NeutriSci.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

 

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ANNOUNCES SUCCESSFUL DEVELOPMENT AND POSITIVE RESULTS FROM INITIAL OBSERVATIONAL PRODUCT TRIALS WITH LEXARIA BIOSCIENCE

Vancouver, British Columbia – January 19, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, Frankfurt-1N9) and Lexaria Bioscience Corp. (“Lexaria”) (LXX.CN) are pleased to announce the successful development and initial trial of the industry’s first cannabinoid / pterostilbene edible tablet utilizing NeutriSci’s and Lexaria’s proprietary and patented technologies.

NeutriSci’s proprietary pterostilbene tablet formula and Lexaria’s technology were combined to produce the first market ready pterostilbene / cannabidiol (CBD) rapid melt edible product. The pre-trial hypothesis focused on whether the combination of NeutriSci’s patented pterostilbene formula and Lexaria’s patented CBD conjugation would prove effective in rapidity of onset, and strength of effect, while delivering improvements in taste.  These initial trial results have demonstrated that the consumer experiences positive effects that occur more immediately, and last longer, while utilizing dose-controlled amounts of CBD.

Based on these positive results, NeutriSci and Lexaria will formalize the JV agreement to market and commercialize a line of edible products using CBD derived from full spectrum hemp oil, which is legal throughout the United States, along with several tetrahydrocannabinol (THC) versions through distribution programs with both existing and new strategic partners.

“We are very pleased with the results of this observational trial, as the initial results have be invaluable in helping NeutriSci open dialogue with several of the world’s largest CBD manufacturers and distributors,” commented Glen Rehman, President of NeutriSci. “The idea of using our sublingual tablet and form factor to create a new line of zero-sugar and dose-controlled cannabinoid edible products will become a reality.  This new ground breaking proprietary tablet and form factor addresses what manufacturers, distributors and consumers have been asking, and positions us to be an industry leader in what will be a multi-billion-dollar industry.”

“This JV is a demonstration of the rapid innovation occurring in the cannabis industry,” commented Chris Bunka, CEO of Lexaria Bioscience. “We are excited to work with NeutriSci; using both company’s technologies, ingredients and form factor to develop healthy cannabinoid products.”

Following the recent approvals for recreational use in certain US states, Industry researchers have reported that the legal cannabis market could exceed $20 Billion by 2020.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

About Lexaria: Lexaria Bioscience Corp. is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. Lexaria’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. Lexaria’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

www.lexariabioscience.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ADDS SOBEYS & SAFEWAY TO ITS LIST OF CANADIAN RETAILERS

Vancouver, British Columbia – January 17, 2017 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, announces its latest distribution agreement with Sobeys and Safeway Canada.

Sobeys Inc. and Safeway Canada are wholly-owned subsidiaries of Empire Company Limited (“Empire”).  Empire is one of the largest food retailers in Canada, with over 260 Sobeys and 183 Safeway supermarkets operating in Canada, with an additional 1,200 stores operating under banners such as IGA and IGA Extra, Thrifty Foods, Foodland, FreshCo, Price Chopper, Lawtons Drugs, Rachelle-Béry, Needs, Marché Bonichoix and Les Marchés Tradition.

NeutriSci President Mr. Glen Rehman stated, “We are pleased to announce our most recent distribution agreement with one of Canada’s preeminent retail groups.  Sobeys and Safeway will offer Canadian consumers a trusted and well established brand in which to find neuenergy.  Continued growth and increased sales of neuenergy is directly proportional to the number of locations neuenergy can be purchased from; these new distribution partners help us achieve just that.  These increased distribution outlets are ultimately increasing revenue.”

Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about neuenergy®, please visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.neutrisci.com.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ANNOUNCES MEMORANDUM OF UNDERSTANDING ESTABLISHING A 50/50 JOINT VENTURE WITH LEXARIA BIOSCIENCE

Vancouver, British Columbia – November 22, 2016 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU, Frankfurt-1N9) and Lexaria Bioscience Corp. (“Lexaria”) (LXX.CN) are pleased to announce the signing of a Memorandum of Understanding forming a 50/50 Joint Venture (the “JV”) to develop and produce a line of healthy edible cannabinoid products using Lexaria’s patented technology and NeutriSci’s proprietary pterostilbene tablet formula and to distribute the products through NeutriSci’s international distribution network.

This JV will test and develop cannabinoid formulations based on NeutriSci’s proprietary sublingual pterostilbene zero-sugar tablet formula and form factor; combining Lexaria’s patented technology which improves the bioavailability and taste of orally ingested cannabinoids. Under the JV, the companies will first develop its edible product using cannabidiol (CBD) derived from full spectrum hemp oil, which is legal throughout the United States, followed by further development using other cannabinoid products such as tetrahydrocannabinol (THC). The JV will ultimately commercialize these potentially unique and proprietary edible products through distribution programs with existing strategic partners.

“We were immediately intrigued when we were approached with the idea of using our sublingual tablet and form factor to create a new line of zero-sugar and dose controlled cannabinoid edible products,” commented Glen Rehman, President of NeutriSci. “By combining Lexaria’s technology to mask taste and increase bioavailability, this JV has all the tools to create a whole new line of healthy cannabinoid edible products, which will have high appeal with today’s health conscious medicinal consumers and recreational users. Consumers and regulatory groups will seek a product that is convenient, safe, dose controlled, effective and ultimately great tasting. This new ground breaking proprietary tablet addresses all of those needs; becoming an industry leading solution in what will be a multi-billion-dollar industry. We expect to complete the JV agreement in the next 4 weeks.”

“This JV is a demonstration of the rapid innovation occurring in the cannabis industry,” commented Chris Bunka, CEO of Lexaria. “We are excited to work with NeutriSci; using both companies’ technologies, ingredients and form factor to develop healthy cannabinoid products sold within NeutriSci’s international distribution network.”

Following the recent approvals for recreational use in certain US states, industry researchers have reported that the legal cannabis market could exceed $20 Billion by 2020.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.getneuenergy.com.

About Lexaria: Lexaria Bioscience Corp. is a food biosciences company with a proprietary technology for improved delivery of bioactive compounds. Lexaria’s lipophilic enhancement technology has been shown to enhance the bioavailability of orally ingested cannabinoids, while also masking taste. This technology promotes healthy ingestion methods, lower overall dosing and higher effectiveness in active molecule delivery. Lexaria’s technology is patent-protected for cannabidiol (CBD) and all other non-psychoactive cannabinoids, and patent-pending for Tetrahydrocannabinol (THC), other psychoactive cannabinoids, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules.

www.lexariabioscience.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward- looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NEUTRISCI ARRANGES $1,500,000 PRIVATE PLACEMENT

Vancouver, British Columbia – November 7, 2016 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (FRANKFURT: 1N9) announces that it has arranged a non-brokered private placement of units (the “Units”) of the Company at a price of ten cents per Unit for gross proceeds of up to $1,500,000.  Each Unit consists of one common share of the Company and one common share purchase warrant, entitling the holder to acquire an additional common share of the Company at a price of $0.18 for a period of eighteen months from the date of issuance.

The Company intends to use the net proceeds of the offering to build inventory and for marketing and advertising programs related to neuenergy®, and for general corporate purposes.

Glen Rehman, President of NeutriSci, stated: “This financing will enable us to execute on the marketing programs we have in place to expand the branding and marketing initiatives of neuenergy, as well as to support the continued increase in sales of neuenergy in our growing retail network.”

The Company may pay a finder’s fee to one or more arms’ length parties who introduce the Company to subscribers, in accordance with the policies of the TSX Venture Exchange.  The common shares, warrants and shares underlying the warrants will be subject to a four-month-and-one-day statutory hold period from the date of issuance.  Closing of the private placement remains subject to the receipt of all regulatory approvals, including the approval of the TSX Venture Exchange.

 

Neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

 

To find out more about neuenergy®, please visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.neutrisci.com.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

Neutrisci Adds Another Canadian Distributor With Winks Convenience – Division of Mac’s

Vancouver, British Columbia – October 11, 2016 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy®, announces its latest distribution agreement with Winks Convenience stores.

Winks is an affiliate retail banner program developed by Mac’s Convenience Stores Inc. for independent convenience stores in Western Canada. Since its beginning in 2003, there are now over 600 Winks members in Western Canada and 150 in Ontario. Winks was developed to assist independent operators that are motivated to grow their business, Winks is a comprehensive program that balances the needs of the independent operator, the suppliers and the distributors.

Alimentation Couche-Tard, the largest convenience store operator in Canada operates the Winks program with such additional operating banners as Couche-Tard and Mac’s here in Canada, the American market is predominately run under the trademark of Circle K. The average store size is 3,000 square feet. There is a network of 5,906 convenience stores, 4,122 of which include gas pumps located in 11 large geographic markets across North America. More than 52,000 people are employed through the Alimentation Couche-Tard retail convenience network and service centers.

NeutriSci President Mr. Glen Rehman stated, “neuenergy® has steadily gained retail traction and consumer demand over the past 12 months. This most recent distribution agreement further expands locations across Canada were neuenergy® can be purchased.  neuenergy® is now available in convenience stores, grocery and specialty retailers across Canada. These diverse channels provide consumers local choices when purchasing neuenergy®, thus driving sales and increased revenue.”

neuenergy® is a revolutionary energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash associated with typical energy products.

To find out more about neuenergy®, please visit www.getneuenergy.com.

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.neutrisci.com.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

NeutriSci Announces Canadian Distribution Agreement And Initial Order with Save-On Foods

Vancouver, British Columbia – September 20, 2016 – NeutriSci International Inc. (the “Company” or “NeutriSci”) (TSX-V: NU) (FRANKFURT: 1N9) the innovator and pioneer behind neuenergy™, announces its latest Canadian distribution agreement with Save-On-Foods, a subsidiary of the Overwaitea Food Group, a Jim Pattison business.

NeutriSci began shipping neuenergy™ to Save-On-Foods in August of 2016, with two subsequent reorders being shipped in September. Store placement is occurring in the aisle and at the front checkout lanes.

Save-On-Foods operates a chain of 135 large corporately owned supermarket/grocery stores in British Columbia, Alberta and Saskatchewan. Known for its unique approach in customizing each store to best suit the needs of the neighbourhood by carrying more than 2,500 locally-made products from more than 2,000 local growers and producers, Save-On-Foods has been innovating and putting customers first for over 100 years.

Save-On-Foods is planning to open as many as 40 stores in Manitoba as well as Saskatchewan over the next two to four years, as well as new stores in northern Canada (i.e. in Whitehorse, Yukon in 2017). More information can be found on www.saveonfoods.com.

Mr. Glen Rehman, President of NeutriSci International, stated, “This latest distribution agreement represents yet another major step forward for NeutriSci and neuenergy. This retail distribution provides consumers another easily assessable retail location in which to purchase neuenergy. Save-on-Foods is also the first grocery retailer to be placing neuenergy™ in each checkout lane as well as in the standard grocery isle. This represents a great accomplishment for neuenergy™ as the checkout lanes are typically the most valuable real estate within the retail environment. We see this relationship as a very solid piece of our Canadian retail distribution program; again driving strong revenues and establishing further brand recognition.”

On Behalf of the Board of Directors of

NEUTRISCI INTERNATIONAL INC.

Glen Rehman
President
NeutriSci International Inc.
Tel: (403) 264-6320
Email: grehman@neutrisci.com

For investor relations inquiries:

Skanderbeg Capital Advisors
Mario Vetro
O: 604‐687‐7130 x105
C: 778‐846‐9970
Mario@skanderbegcapital.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release may include forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include market prices, exploitation and exploration successes, continued availability of capital and financing, and general economic, market or business conditions. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

About NeutriSci International Inc.: NeutriSci specializes in the innovation, production and formulation of nutraceutical products. Established in 2009, NeutriSci is currently focused on building sustainable sales models with Convenience, Chain Drug, and Mass Market and Supermarket retailers for neuenergy™, the Company’s natural energy and focus supplement that has at its core, the beneficial effects of blueberries. neuenergy™ contains a unique patented combination of blueberries (pterostilbene) and naturally derived caffeine. neuenergy™ provides sustained energy and focus without sugar, calories, carbs or the jitters typically associated with energy products. For more information, visit: www.neutrisci.com.

Statements in this press release have not been evaluated by the Food and Drug Administration. Products or ingredients are not intended to diagnose, treat, cure or prevent any disease.

ABOUT US

NeutriSci International Inc. is an Alberta based marketing, development and distribution company targeting the multi-billion dollar Nutraceutical market. We develop effective marketing and branding strategies for nutraceutical partners around the world.

Privacy Policy

GET IN TOUCH

NeutriSci International Inc.
Toronto: (TSX-V: NU)
Frankfurt: (1N9)
OTCQB: (NRXCF)

Suite #1A, 4015 1st St SE

Calgary, AB, Canada
T2G 4X7

Office: 1.403.264.6320
Fax: 1.403.252.2106

Email: info@neutrisci.com

TRACK OUR STOCK
NU.V
+5.000%
NEUTRISCI INTERNATIONAL INC
  • Share price:
    0.105
  • Day high:
    0.105
  • Year high:
    0.250
@getneuenergy Updates